Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 2/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.39 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28001436 | 0.81 | HDAC4 (0.41) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL4905952 | 0.79 | HDAC4 (0.40) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL17006481 | 0.78 | HDAC4 (0.36) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL1502492 | 0.77 | HDAC4 (0.35) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL9121246 | 0.76 | HDAC4 (0.42) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL4908231 | 0.76 | GSTP1 (0.31) | GSTP1 | |
| SCHEMBL27997549 | 0.76 | HDAC4 (0.37) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL27844843 | 0.75 | HDAC2 (0.48) | HDAC4HDAC2HDAC8HDAC6HDAC3 | |
| SCHEMBL222929 | 0.75 | GSTP1 (0.31) | GSTP1 | |
| SCHEMBL93925 | 0.72 | HDAC4 (0.42) | HDAC4HDAC2HDAC8HDAC6HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970519-B1 | ACRYLIC BLOCK COPOLYMERS | AVERY DENNISON CORP (US) | 2019-07-03 | — | — | EP | claimed |
| US-9550927-B2 | Acrylic block copolymers | AVERY DENNISON CORPORATION (US) | 2017-01-24 | — | — | US | claimed |
| EP-2970519-A1 | ACRYLIC BLOCK COPOLYMERS | Avery Dennison Corporation (US) | 2016-01-20 | — | — | EP | claimed |
| US-20140303314-A1 | Acrylic Block Copolymers | AVERY DENNISON CORPORATION (US) | 2014-10-09 | — | — | US | claimed |
| WO-2014152573-A1 | ACRYLIC BLOCK COPOLYMERS | AVERY DENNISON CORPORATION (US) | 2014-09-25 | — | — | WO | claimed |
| US-10563011-B2 | Dual curable composition | CURATOLO BENEDICT S (US) | 2020-02-18 | — | — | US | disclosed |
| EP-2970519-B1 | ACRYLIC BLOCK COPOLYMERS | AVERY DENNISON CORP (US) | 2019-07-03 | — | — | EP | disclosed |
| US-10266717-B2 | Corrosion-resistant, chromium-free, self-priming coatings curable by ultraviolet light | Dr. Ben Curatolo, Inc. (US) | 2019-04-23 | — | — | US | disclosed |
| US-10150835-B2 | Dual curable composition | CURATOLO BENEDICT S (US) | 2018-12-11 | — | — | US | disclosed |
| US-9550927-B2 | Acrylic block copolymers | AVERY DENNISON CORPORATION (US) | 2017-01-24 | — | — | US | disclosed |
| US-20170009010-A1 | DUAL CURABLE COMPOSITION | CURATOLO BENEDICT S (US) | 2017-01-12 | — | — | US | disclosed |
| EP-2970519-A1 | ACRYLIC BLOCK COPOLYMERS | Avery Dennison Corporation (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2000035671-A1 | PACKAGING MATERIAL HAVING IMPROVED BARRIER PROPERTIES | SARTOMER COMPANY, INC. (US) | 2000-06-22 | — | — | WO | disclosed |
| EP-0891401-A4 | RADIATION-CURABLE COATING COMPOSITIONS | AVERY DENNISON CORP (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-2000026021-A1 | SECURITY COATINGS FOR LABEL MATERIALS | AVERY DENNISON CORPORATION (US) | 2000-05-11 | — | — | WO | disclosed |
| US-5888649-A | ACRYLATED RESIN | AVERY DENNISON CORPORATION (US) | 1999-03-30 | — | — | US | disclosed |
| WO-1999009107-A1 | RADIATION-CURABLE RELEASE COATING COMPOSITIONS | AVERY DENNISON CORPORATION (US) | 1999-02-25 | — | — | WO | disclosed |
| EP-0891401-A1 | RADIATION-CURABLE COATING COMPOSITIONS | AVERY DENNISON CORPORATION (US) | 1999-01-20 | — | — | EP | disclosed |
| US-5804301-A | FREE OF METHACRYLIC FUNCTIONALIZED COLLOIDAL SILICA | AVERY DENNISON CORPORATION (US) | 1998-09-08 | — | — | US | disclosed |
| WO-1997025389-A1 | RADIATION-CURABLE COATING COMPOSITIONS | AVERY DENNISON CORPORATION (US) | 1997-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10563011-B2 | Dual curable composition | CCNB2, UBE2G2, ERH | HDAC4 2241/4885HDAC2 964/4885HDAC8 1314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.